Vanessa Cervantes

Appearances

VALIDATION OF THE AGA CLINICAL CARE PATHWAY AND NEW AASLD GUIDANCE FOR NONALCOHOLIC FATTY LIVER DISEASE IN A PROSPECTIVE COHORT OF PATIENTS WITH TYPE 2 DIABETES
Date
May 6, 2023
The rising prevalence of non-alcoholic fatty liver disease (NAFLD) will result in increased referrals to gastroenterology and hepatology units…
Presenter
Veeral Ajmera
Speakers
Vanessa Cervantes
Kaleb Tesfai
Ricki Bettencourt
Lisa Richards
Rohit Loomba
DEVELOPMENT AND VALIDATION OF THE FAMILIAL RISK SCORE TO DETECT ADVANCED FIBROSIS IN NAFLD: A PROSPECTIVE, MULTICENTER STUDY
Date
May 6, 2023
The rising prevalence of non-alcoholic fatty liver disease (NAFLD) will result in increased referrals to gastroenterology and hepatology units…
Presenter
Daniel Huang
Speakers
Noora Ahlholm
Panu Luukkonen
Kimmo Porthan
Maral Amangurbanova
Richele Bettencourt
Harris Siddiqi
Vanessa Cervantes
Christie Hernandez
Scarlett Lopez
Lisa Richards
Katriina Nemes
Helena Isoniemi
Hannele Yki-Järvinen
Rohit Loomba